baber/WOPTO huggingface dataset:
Patent JP-3008796-B2 (JP)
IPC: G01B11/00
Filed: 1994-12-22
Granted: 2000-02-14
Abstract: An illuminating device for use in a terminated cable part inspection device for a stripped terminal crimping machine is of a reflected image capturing type and can ensure a satisfactory illuminance required for photographing. The stripped terminal crimping machine includes a stripping portion and a terminal crimping portion between which the terminated cable part inspection device (8) is located on a bidirectional path (P). The terminated cable part inspection device (8) includes an image pickup camera (11) having a high shutter speed, an illuminating means (12), and a detecting means (13) including first and second sensors (31, 32) for detecting the cable. The illuminating means (12) includes a pair of illuminating portions (20) on opposite sides of a photographing path (19) of the image pickup camera (11) for directing illumination in substantially the same direction as a photographing direction toward a cable end passing therethrough along the bidirectional path (P) and elongated in substantially the same direction as a longitudinal direction of the cable. The illuminating portions (20) are arranged in inwardly inclined relation. <IMAGE>
Patent JP-3299235-B2 (JP)
IPC: B29C48/395
Filed: 1999-11-12
Granted: 2002-07-08
Abstract: A back-flow prevention apparatus includes a screw body; a screw head (14) attached to the screw body; a first resin passage (37) formed on a first ring; a second resin passage (47) formed on a second ring (32) located adjacent to and rotatable relative to the first ring (31); a drive unit. for rotating a screw; and a controller. A rotation restriction mechanism (39,49) is disposed between the first and second rings such that communication is established between the first and second resin passages or sealing is effected upon rotation of the screw (12). The controller (171) includes a resin-pressure reduction unit for reducing the pressure of resin in the space located forward of the screw head after completion of a metering step but before initiation of sealing. Since the pressure of resin in the space located forward of the screw head has been reduced when sealing is effected upon rotation of the screw, the resin in the space located forward of the screw head is prevented from flowing in the opposite rotational direction upon rotation of the screw.
Patent JP-2799348-B2 (JP)
Inventor: CHUNG BONG HYUN
IPC: C12P21/02
Filed: 1994-12-09
Granted: 1998-09-17
Abstract: The present invention relates to secretion signal peptides of inulinase derived from Kluyveromyces marxianus, which cause a heterologous protein produced in a yeast cell to be secreted almost completely into the extracellular medium; nucleotide sequences encoding said secretion signal sequences; expression and secretion vectors comprising nucleotide sequences encoding said secretion signal peptides; recombinant yeast cells transformed with said expression and secretion vectors; and a process for producing heterologous proteins by culturing said recombinant yeast cells. <IMAGE>
Patent JP-3387872-B2 (JP)
IPC: C02F3/00
Filed: 1999-11-26
Granted: 2003-03-17
Abstract: In a ship-borne waste water treatment system the effluent is released into a biological reactor system having a suspended high concentration of biomass. Following treatment, waste water flows over a membrane separating wastes into permeate and retentate. The permeate is re-used either for drinking or for general purposes, or is partly returned to the reactor system. The retentate is partially returned to the reactor system. The reactor operates using the high cell density fermentation process of 30g biomass/l. Waste water released to the biological system is first pre-filtered. Waste water is oxygenated within the reactor by air or oxygen pressurized to between 1 and 1.2 bar. Water is released to the membrane at a controlled temperature and at an enhanced pressure. Permeate is returned to the reactor when the level of waste water (original waste water and retentate) in the reaction system has reached a pre-defined lower threshold. It is released when the waste water level (original waste water and retentate) has reached an upper pre-defined level in the reactor system. Also claimed is a suitable waste water treatment assembly.
Patent JP-3902663-B2 (JP)
IPC: A61K48/00
Filed: 1997-05-30
Granted: 2007-04-11
Abstract: The invention relates to a novel lipid kinase which is part of the PI3 Kinase family. PI3 Kinases catalyze the addition of phosphate to inositol generating inositol mono, di and triphosphate. Inositol phosphates have been implicated in regulating intracellular signaling cascades resulting in alternations in gene expression which, amongst other effects, can result in cytoskeletal remodeling and modulation of cellular motility. More particularly the invention relates to a novel human PI3 Kinase, p110Delta which interacts with p85, has a broad phosphinositide specificity and is sensitive to the same kinase inhibitors as PI3 Kinase p110A. However, in contrast to previously identified PI3 Kinases which show a ubiquitous pattern of expression, p110Delta is selectively expressed in leucocytes. Importantly, p110Delta shows enhanced expression in most melanomas tested and therefore may play a crucial role in regulating the metastatic property exhibited by melanomas. The identification of agents that enhance or reduce p110Delta activity may therefore prevent cancer metastatis.
Patent JP-4009318-B2 (JP)
IPC: C07H15/18
Filed: 1996-06-05
Granted: 2007-11-14
Abstract: Novel substituted liposaccharides useful as in the prophylactic and affirmative treatment of endotoxemia including sepsis, septicemia and various forms of septic shock and methods of using these agents are provided. Also provided are methods of preparing these agents and intermediates useful therein.
Patent JP-4409631-B2 (JP)
IPC: C12N15/87
Filed: 1994-06-10
Granted: 2010-02-03
Abstract: The invention provides a novel retroviral packaging system, in which retroviral packaging constructs and packagable vector transcripts are produced from high expression plasmids by transfection in human cells. High titers of recombinant retrovirus are produced in infected cells. The methods of the invention include the use of the novel retroviral constructs to transduce primary human cells, including T cells and human hematopoietic stem cells, with foreign genes by cocultivation at high efficiencies. The invention is useful for the rapid production of high viral supernatants, and to transduce with high efficiency cells that are refractory to transduction by conventional means.
Patent JP-3494651-B2 (JP)
IPC: A61P25/28
Filed: 1994-07-07
Granted: 2004-02-09
Abstract: PCT No. PCT/FR94/00841 Sec. 371 Date Jan. 11, 1996 Sec. 102(e) Date Jan. 11, 1996 PCT Filed Jul. 7, 1994 PCT Pub. No. WO95/01791 PCT Pub. Date Jan. 19, 1995The present invention relates to the use of efaroxan and derivatives for the treatment of Alzheimer's disease.
Patent JP-4017193-B2 (JP)
IPC: G06F19/00
Filed: 1998-06-19
Granted: 2007-12-05
Abstract: Analytes in a sample are resolved by retentate chromatography in a procedure involving adsorbing the analytes on a substrate under a plurality of different selectivity conditions, and detecting the analytes retained on the substrate by desorption spectrometry. The methods are useful in biology and medicine, including clinical diagnostics and drug discovery.
Patent JP-3606872-B2 (JP)
IPC: A61P35/00
Filed: 1994-07-19
Granted: 2005-01-05
Abstract: PCT No. PCT/FR94/00898 Sec. 371 Date Jan. 19, 1996 Sec. 102(e) Date Jan. 19, 1996 PCT Filed Jul. 19, 1994 PCT Pub. No. WO95/03312 PCT Pub. Date Feb. 2, 1995Novel fluorinated derivatives of the vinblastine and vinorelbine family of general formula (1),    <IMAGE>  1  wherein the symbols have the meanings indicated in the Specification and Claims, and the therapeutically-acceptable salts of these molecules, as well as pharmaceutical compositions thereof. The invention also concerns the application of said compounds in the treatment of a cancer pathology and their methods of preparation.
Patent JP-2663165-B2 (JP)
IPC: G09B23/30
Filed: 1988-08-24
Granted: 1997-10-15
Abstract: PCT No. PCT/AU88/00319 Sec. 371 Date Feb. 20, 1990 Sec. 102(e) Date Feb. 20, 1990 PCT Filed Aug. 24, 1988 PCT Pub. No. WO89/01812 PCT Pub. Date Mar. 9, 1989.The present invention provides a doll (10) which is arranged to be fed both liquids and non-liquids or solids. These are received in respective first and second chambers (20, 22). The present invention also provides a chamber pot (54) for a doll (10). Further, the present invention provides a casing (98) for enclosing or enveloping a doll (10) to simulate the womb. The present invention allows for a visual explanation of childbirth and childcare to be given to young children. This may be supplemented by instructions from another source, e.g. an adult or text.
Patent JP-4633867-B2 (JP)
IPC: A61P35/00
Filed: 1996-06-26
Granted: 2011-02-16
Abstract: We have discovered that by using a recombinant viral vector, preferably a pox virus vector having at least one insertion site containing a DNA segment encoding prostate-specific antigen (PSA), operably linked to a promoter capable of expression in the host, a specific humoral and cellular immune response to PSA can be generated. The method preferably comprises introducing a sufficient amount of the recombinant pox virus vector into a host to stimulate the immune response, and contacting the host with additional PSA at periodic intervals thereafter. The additional PSA may be added by using a second pox virus vector from a different pox genus. In another embodiment, additional PSA can be added by contacting the host with PSA by a variety of other methods, including in one preferred embodiment adding PSA. The PSA may be formulated with an adjuvant or in a liposomal formulation.
Patent JP-2627673-B2 (JP)
IPC: C09J7/02
Filed: 1989-06-22
Granted: 1997-07-09
Abstract: A substrate is provided with a release surface by application of an emulsion of a vinyl-addition silicone system and catalyst therefor and a particulate component, preferably a resin. The vinyl addition silicone system is cured upon application of heat and removal of water.
Patent JP-3273787-B2 (JP)
IPC: A01N43/74
Filed: 1992-10-12
Granted: 2002-04-15
Abstract: PCT No. PCT/GB92/01860 Sec. 371 Date Feb. 16, 1994 Sec. 102(e) Date Feb. 16, 1994 PCT Filed Oct. 12, 1992 PCT Pub. No. WO93/08180 PCT Pub. Date Apr. 29, 1993.    <IMAGE>  (I)  Fungicidal compounds having general formula (I) and stereoisomers thereof, in which A, B, C and D are independently H, halo, C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl, C1-4 alkylthio, cyano, nitro, C1-4 haloalkyl, phenoxyobenzyl or benzyloxy, the phenyl moieties of any of the foregoing being optionally substituted with one or more of halo, C1-4 alkyl, C1-4 alkoxy, nitro or cyano; X is oxygen, sulphur or NR, in which R is H or C1-4 alkyl; and W is CH3O.CH=C.CO.CH3or CH3O.N=C.CONR1R2, in which R1 and R2 are independently H or methyl.
Patent JP-2741636-B2 (JP)
IPC: G04B37/14
Filed: 1994-09-02
Granted: 1998-04-22
Abstract: PCT No. PCT/FR94/01035 Sec. 371 Date Mar. 1, 1996 Sec. 102(e) Date Mar. 1, 1996 PCT Filed Sep. 2, 1994 PCT Pub. No. WO95/06902 PCT Pub. Date Mar. 9, 1995A wrist watch with interchangeable strap (10) comprises a supporting element (20) with a body (21) and a strap (10) forming a single unit. The strap includes a central slot (11) designed to be fitted about the body (21). A cover (30) can be folded down over the strap (10) by rotation about a hinge (40) formed in the supporting element (20). The cover (30) and supporting element (20) includes a clasp (51, 52) and a button (60) on the supporting element (20) for opening the cover (30).
Patent JP-3431139-B2 (JP)
IPC: C22C9/00
Filed: 1991-05-30
Granted: 2003-07-28
Abstract: A lead frame comprising a lead frame base of a Cu alloy and an oxide layer formed thereon. The Cu alloy is the one which has dispersed particles, part of which distribute and is exposed on the surface of the alloy, or the one containing P of 30 ppm or less. In the case of the lead frame base made of the alloy containing the dispersed particles, since an oxide layer including oxides of the dispersed particles is formed, the adhesiveness of the oxide layer is improved. In the case of the lead frame base made of the Cu alloy including a specified amount of P, an oxide layer having an excellent adhesiveness can be formed too. By virtue of such oxide layers, the adhesiveness to a shielding resin is improved and the reliability of a semiconductor package can be improved. <IMAGE>
Patent JP-3588116-B2 (JP)
IPC: A61K31/505
Filed: 1994-09-21
Granted: 2004-11-10
Abstract: PCT No. PCT/EP94/03148 Sec. 371 Date May 31, 1995 Sec. 102(e) Date May 31, 1995 PCT Filed Sep. 21, 1994 PCT Pub. No. WO95/09851 PCT Pub. Date Apr. 13, 1995Described are N-phenyl-2-pyrimidineamine derivatives of formula I    <IMAGE>  (I)  wherein R1 is a substituted cyclic radical, the cyclic radical being bonded at a ring carbon atom in each case and being selected from phenyl, pyridyl, pyrazinyl, thiazolyl, pyrimidinyl, pyridazinyl and imidazolyl, and the substituents of the above-mentioned cyclic radical being selected from one or more of the groups halogen, cyano, carbamoyl, -C(=O)-OR3, -C(=O)-R4, -SO2-N(R5)-R6, -N(R7)-R8, -OR9 and fluorine-substituted lower alkyl, wherein R3, R4, R5, R6, R7, R8 and R9 are each independently of the others hydrogen or lower alkyl that is unsubstituted or substituted by mono- or di-lower alkylamino; and R2 is selected from halogen, cyano, carbamoyl, -C(=O)-OR10, -C(=O)-R11, -SO2-N(R12)-R13, -N(R14)-R15, -OR16 and fluorine-substituted lower alkyl, wherein R10, R11, R12, R13, R14, R15 and R16 are each independently of the others hydrogen or lower alkyl that is unsubstituted or substituted by mono- or di-lower alkylamino. Those compounds can be used, for example, in the treatment of tumour diseases.
Patent JP-3068183-B2 (JP)
IPC: C08F8/04
Filed: 1991-05-10
Granted: 2000-07-24
Abstract: Polyvinyl halide resin absent allylic halogen is disclosed. Another polyvinyl halide resin absent allylic halogen, allylic branching and unsaturation is also disclosed. The compositions of this invention are prepared by contacting any polyvinyl halide resin with a hydrogen-substituting compound that has a selective affinity for the allylic halogens.
Patent JP-3426236-B2 (JP)
IPC: G01N27/447
Filed: 1993-11-05
Granted: 2003-07-14
Abstract: Separation media for electrophoresis, and methods of filling and flushing of electrophoretic devices such as capillaries are described. By preparing submicron to above-micron sized cross-linked gel particles and using gel swelling equilibrium concepts, such devices can be easily filled and flushed. Gel particles can be prepared by inverse emulsion, precipitation and suspension polymerization. These particles can be swollen and collapsed by small changes in temperature, pH, and ionic strength of solvent. Other approaches involve the use of polyelectrolyte complexes and copolymers of hydrophobic and hydrophilic repeat units. Both systems can be gelled by changing temperature and ionic strength of the solvent.
Patent JP-3286919-B2 (JP)
IPC: B01L3/00
Filed: 1993-11-02
Granted: 2002-05-27
Abstract: A sample collection container having inner and outer chambers. The container may be fitted with upper and lower stoppers to provide a vacuum within the container. The device is adapted for the collection of a fluid, such as blood, in the inner chamber. The blood then passes from the inner chamber to the outer chamber upon releasing the vacuum. A concentrate of fluid components of blood, cellular debris, and contaminating microorganisms, if present, may be left in the inner chamber, and be removed subsequently from the inner chamber for testing for the presence of contaminating microorganisms.
Patent JP-3229332-B2 (JP)
IPC: B29C65/58
Filed: 1997-09-11
Granted: 2001-11-19
Abstract: A material and method is provided for lining man-entry sized pipes and securing the lining to the pipe. The lining comprises a plurality of adjacent, unplasticized polyvinyl chloride panel segments circumferentially curved within the pipe, each including an interior channel through which grout may be injected. Upon the grout's curing, the grout provides strength and support for a second layer of grout injected into an annulus between the pipe's inner surface and an outer surface of the lining.
Patent JP-3323200-B2 (JP)
IPC: B01D1/24
Filed: 1993-02-10
Granted: 2002-09-09
Abstract: An apparatus for extracting solid residues from an aqueous slurry. The slurry is applied to the upper surfaces of disks that rotate in a hollow cylindrical vessel so that an evaporation enclosure is defined by the vessel and at least in part by the upper surfaces of the disks. Oscillating slurry dispensing arms are oriented radially relative to the axis of a hollow shaft that supports the disks. Slurry flattening rollers press the slurry on to these disk upper surfaces and slurry scraping means remove the residue from the rotating disk upper surfaces. Finally, a condensation enclosure is provided for removing liquid condensate from the vapor produced in the evaporation disclosure, and means is provided for eliminating non-condensable gases periodically from a condensation enclosure.
Patent JP-3100062-B2 (JP)
IPC: A63B23/20
Filed: 1993-03-08
Granted: 2000-10-16
Abstract: PCT No. PCT/AT93/00041 Sec. 371 Date Nov. 9, 1993 Sec. 102(e) Date Nov. 9, 1993 PCT Filed Mar. 8, 1993 PCT Pub. No. WO93/17619 PCT Pub. Date Nov. 9, 1993.A device for monitoring the contractibility of the pelvic floor muscles is provided in which a probe, having a plurality of elastically deformable chambers, is connected to a fluid filled conduit and a display device, which is connected to the fluid filled conduit. Such a device is effective in obtaining more isolated measurements for muscles being monitored and reducing interference from other muscles. The device can be used therapeutically to monitor progress in training of the pelvic floor muscles.
Patent JP-3822912-B2 (JP)
IPC: H04L1/00
Filed: 1997-09-26
Granted: 2006-09-20
Abstract: Apparatus, and an associated method, selectively transmits packets of message data between a sending and a receiving station. When a packet of message data is received at a receiving station, the receiving station acknowledges reception thereat of the packet with an acknowledgment response signal, transmitted back to the sending station. If the sending station fails to detect an acknowledgment response signal, a packet of activity-request data is sent to the receiving station. If the receiving station fails to acknowledge reception of the packet of activity-request data, a determination is made that the receiving station would be unlikely to be able to receive an additional packet of message data. A channel to be used to transmit the packet of message data can instead be reallocated for other purposes.
Patent JP-3088468-B2 (JP)
IPC: A61K8/00
Filed: 1996-10-18
Granted: 2000-09-18
Abstract: A hair styling composition comprising: (a) from about 0.1% to about 15%, by weight, of an adhesive polymer, said polymer being characterized by an organic polymeric backbone wherein said polymer is substantially free of silicone; (b) from about 0.1% to about 15%, by weight, of a silicone grafted adhesive polymer, said polymer being characterized by an organic polymeric backbone, compatible with said adhesive polymer of (a) wherein said silicone grafted adhesive polymer has silicone macromers grafted to said backbone and wherein the number average molecular weight of said silicone macromers is greater than about 500; (c) from about 0.1% to about 15%, by weight, of a hydrocarbon solvent selected from the group consisting of C10-C14 branched chain hydrocarbons, and mixtures thereof having a boiling point of from about 105° C. to about 260° C.; (d) a polar solvent phase comprising from about 80% to about 99%, by weight of the composition, of a polar solvent selected from the group consisting of water and C2-C3 monohydric alcohols, and mixtures thereof, wherein said composition contains no more than about 15%, by weight, of C3 monohydric alcohol; wherein said organic polymer backbone is soluble in said polar solvent phase, and said silicone macromers of said hair setting polymer are soluble in said hydrocarbon solvent.
Patent JP-3532572-B2 (JP)
IPC: C12P7/56
Filed: 1995-12-01
Granted: 2004-05-31
Abstract: A method of processing waste is disclosed wherein the municipal solid waste is segregated and processed to recover reusable rubber, metal, plastic, glass and the remaining organic portion of the waste stream is used to make lactic acid and other chemicals. One process utilizes a pretreatment step with dilute sulfuric acid to reduce the heavy metal content of the cellulosic component of the municipal solid waste which may contaminate the produced lactic acid or inhibit the fermentation of the sugars obtained from such waste. In another, the heavy metal content of the cellulosic component of municipal solid waste is removed via an ionic exchange process, after hydrolysis with sulfuric acid. A process for an economical, energy efficient production of lactic acid from municipal solid waste is also disclosed.
Patent JP-3307396-B2 (JP)
IPC: C07D233/61
Filed: 1995-01-03
Granted: 2002-07-24
Abstract: Phenylacetic acid derivs. of formula (I), and their salts. X = NOMe. CHOMe, CHMe or CHEt; R<1> = H or Q; m = 0, 1 or 2; R<2> = CN, NO2, CF3, halo, Q or QO; R<3> = H, CN, NO2, OH, NH2, halo, Q, QO, QS, QNH ; R<4> = H, Cy, CyO, CyS, CyNH, Ar, ArO, ArS; Q = 1-4C alkyl; Cy = 3-6C cycloalkyl; Ar = aryl; R<5> = H, 1-10C alkyl, Cy, 2-10C alkenyl, 2-10C alkynyl, 2-10C alkenylcarbonyl, 1-10C alkycarbonyl, 3-10C alkynylcarbonyl or 1-10C alkylsulphonyl.
Patent JP-3810079-B2 (JP)
IPC: A61K31/352
Filed: 1995-02-10
Granted: 2006-08-16
Abstract: PCT No. PCT/EP95/00489 Sec. 371 Date Jul. 9, 1996 Sec. 102(e) Date Jul. 9, 1996 PCT Filed Feb. 10, 1995 PCT Pub. No. WO95/22325 PCT Pub. Date Aug. 24, 1995The present invention relates to pharmaceutical compositions containing as active ingredient micronized nebivolol of formula (I) and ways of preparing said compositions.    <IMAGE>  (1)    <IMAGE>
Patent JP-4210330-B2 (JP)
IPC: A61P35/00
Filed: 1996-12-23
Granted: 2009-01-14
Abstract: A method for the treatment of, or prevention of a disease and/or condition in a patient which is treatable or preventable by receptor mediated treatment is provided, the method comprising the administration of an effective amount of a medicine and/or therapeutic agent with an effective amount of a binding agent (other than hyaluronan, a pharmaceutically acceptable salt thereof or other such forms of hyaluronic acid) which binding agent is mixed with the medicine and/or therapeutic agent and which binding agent binds at the site of the disease or condition with at least one of the group of binding domains selected from: (a) RSHKTRSHH {Single-Letter Code of Amino Acids} also identified as: Arg-Ser-His-Lys-Thr-Arg-Ser-His-His {Three-Letter Code of Amino Acids} also identified as: <u>CGC-TCG-CAC-AAG-ACC-AGG-TCG-CAC-CAC</u> (Another Code); (b) RPHFHKR {Single Letter Code of Amino Acids} also identified as: Arg-Pro-His-Phe-His-Lys-Arg {Three-Letter Code of Amino Acids} also identified as <u>CGG-CCC-CAC-TTC-CAC-AAG-CGG</u> (Another Code).
Patent JP-3880624-B2 (JP)
IPC: C12N15/09
Filed: 1997-01-09
Granted: 2007-02-14
Abstract: Mutants of 2,5-diketo-D-gluconic acid reductase A an enzyme used to produce 2-keto-L-gluconic acid, a precursor of ascorbic acid (vitamin C), are prepared by site-directed mutagenesis. These mutants may exhibit one or more of the following characteristics: improved temperature stability, increased resistance to substrate inhibition, increased turnover of the substrate by the enzyme and increased affinity for the substrate.
Patent JP-3532923-B2 (JP)
IPC: C12H1/056
Filed: 1995-03-28
Granted: 2004-05-31
Abstract: A method of treating beverage which comprises contacting the beverage with polyvinyl polypyrrolidone and subsequently centrifuging the beverage to remove the polyvinyl polypyrrolidone.